Takao Katoh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Takao Katoh has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Eiichi Watanabe
Department of Cardiology Fujita Health University Bantane Hospital Nagoya Japan
3 shared publications- Hiroshi Morita
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
3 shared publications Masaaki Yashima
Department of Cardiology Nippon Medical School Tokyo Japan
3 shared publications- Naokata Sumitomo
Department of Pediatric Cardiology Saitama Medical University International Medical Center Saitama Japan
3 shared publications Norihiro Ueda
Department of Medical Education Nagoya City University Nagoya Japan
3 shared publicationsSatoshi Ogawa
Department of Cardiovascular Medicine, Keio University School of Medicine, Tokyo, Japan
3 shared publications
Latest Publications
- Open Access
- 27 November 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 40 (1) , 17-25
Expert consensus document on automated diagnosis of the electrocardiogram: The task force on automated diagnosis of the electrocardiogram in Japan part 3: Inappropriate internal processing in the automatic diagnosis of electrocardiograms and its problems
Computer diagnosis of electrocardiograms is widely used to provide useful information in clinical practice and medical checkups. However, it is common for users to be confused by the inappropriate diagnosis. We illustrate some examples of inappropriate automatic diagnoses and discuss the actual situation of inappropriate automatic processing and its problems.
- 27 November 2023
- Published by Wiley in Journal of Arrhythmia
- Vol. 40 (1) , 17-25
Open AccessExpert consensus document on automated diagnosis of the electrocardiogram: The task force on automated diagnosis of the electrocardiogram in Japan part 3: Inappropriate internal processing in the automatic diagnosis of electrocardiograms and its problems
Computer diagnosis of electrocardiograms is widely used to provide useful information in clinical practice and medical checkups. However, it is common for users to be confused by the inappropriate diagnosis. We illustrate some examples of inappropriate automatic diagnoses and discuss the actual situation of inappropriate automatic processing and its problems.
- Open Access
- 19 October 2021
- Published by Wiley in Journal of Arrhythmia
- Vol. 37 (6) , 1427-1433
Expert consensus document on automated diagnosis of the electrocardiogram: The task force on automated diagnosis of the electrocardiogram in Japan
It is important to objectively grasp the current status of automated electrocardiogram (ECG) diagnosis. This report aimed to analyze and evaluate ECG records that our members have encountered as an inappropriate diagnosis in real-world clinical practices.
- 19 October 2021
- Published by Wiley in Journal of Arrhythmia
- Vol. 37 (6) , 1427-1433
Open AccessExpert consensus document on automated diagnosis of the electrocardiogram: The task force on automated diagnosis of the electrocardiogram in Japan
It is important to objectively grasp the current status of automated electrocardiogram (ECG) diagnosis. This report aimed to analyze and evaluate ECG records that our members have encountered as an inappropriate diagnosis in real-world clinical practices.
- Open Access
- 14 June 2021
- Published by Wiley in Journal of Arrhythmia
- Vol. 37 (4) , 871-876
Expert consensus document on automated diagnosis of the electrocardiogram: The task force on automated diagnosis of the electrocardiogram in Japan. Part 1: Nomenclature for diagnosis and abnormal findings
As these terms should accurately represent the abnormal findings and conditions as much as possible, we propose to unify these terms into terminologies that are not confusing and easy to understand for everyone.
- 14 June 2021
- Published by Wiley in Journal of Arrhythmia
- Vol. 37 (4) , 871-876
Open AccessExpert consensus document on automated diagnosis of the electrocardiogram: The task force on automated diagnosis of the electrocardiogram in Japan. Part 1: Nomenclature for diagnosis and abnormal findings
As these terms should accurately represent the abnormal findings and conditions as much as possible, we propose to unify these terms into terminologies that are not confusing and easy to understand for everyone.
- Open Access
- 1 January 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 13 (1) , 98-107
Cardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from theMATCHstudy
Objectives To investigate the cardiovascular safety of mirabegron add-on treatment to tamsulosin in male patients with residual overactive bladder symptoms. Methods This was a post hoc analysis of MATCH, the first double-blind, placebo-controlled study comparing mirabegron and placebo as add-on therapy to tamsulosin for treatment of overactive bladder in men with lower urinary tract symptoms. The analysis focused on treatment-emergent adverse events relating to the cardiovascular system or blood pressure, and changes in vital signs during 12 weeks of follow-up. Results Cardiovascular-related treatment-emergent adverse events were reported by 6/566 patients, although only one serious treatment-emergent adverse event was related to treatment (unstable angina in the tamsulosin + placebo group). Hypertension (two patients) and increased blood pressure (one patient) were reported in the tamsulosin + placebo group, but there were no blood pressure-related treatment-emergent adverse events among tamsulosin + mirabegron patients. There were no clinically meaningful changes from baseline in blood pressure, and changes in pulse rate were small (+1.2 bpm in the tamsulosin + mirabegron group). Increased pulse rate was more frequent with tamsulosin + mirabegron than with tamsulosin + placebo in older patients, although within the normal range. Conclusions Cardiovascular-related adverse events were uncommon in both treatment groups. Mirabegron is a well-tolerated add-on therapy to tamsulosin in Japanese and Korean males with residual overactive bladder symptoms.
- 1 January 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 13 (1) , 98-107
Open AccessCardiovascular safety of mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from theMATCHstudy
Objectives To investigate the cardiovascular safety of mirabegron add-on treatment to tamsulosin in male patients with residual overactive bladder symptoms. Methods This was a post hoc analysis of MATCH, the first double-blind, placebo-controlled study comparing mirabegron and placebo as add-on therapy to tamsulosin for treatment of overactive bladder in men with lower urinary tract symptoms. The analysis focused on treatment-emergent adverse events relating to the cardiovascular system or blood pressure, and changes in vital signs during 12 weeks of follow-up. Results Cardiovascular-related treatment-emergent adverse events were reported by 6/566 patients, although only one serious treatment-emergent adverse event was related to treatment (unstable angina in the tamsulosin + placebo group). Hypertension (two patients) and increased blood pressure (one patient) were reported in the tamsulosin + placebo group, but there were no blood pressure-related treatment-emergent adverse events among tamsulosin + mirabegron patients. There were no clinically meaningful changes from baseline in blood pressure, and changes in pulse rate were small (+1.2 bpm in the tamsulosin + mirabegron group). Increased pulse rate was more frequent with tamsulosin + mirabegron than with tamsulosin + placebo in older patients, although within the normal range. Conclusions Cardiovascular-related adverse events were uncommon in both treatment groups. Mirabegron is a well-tolerated add-on therapy to tamsulosin in Japanese and Korean males with residual overactive bladder symptoms.
- 11 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e278-e278b
278 Safety and effectiveness of mirabegron in patients with overactive bladder (OAB): Results of two Japanese post-marketing surveys
- 11 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e278-e278b
278 Safety and effectiveness of mirabegron in patients with overactive bladder (OAB): Results of two Japanese post-marketing surveys
- Open Access
- 1 January 2011
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 78 (1) , 22-29
Clinical Significance of Synthesized Posterior/Right-Sided Chest Lead Electrocardiograms in Patients with Acute Chest Pain
Background: 12-lead electrocardiograms (ECGs) provide insufficient information for the accurate diagnosis of posterior and/or right ventricular acute myocardial infarction (AMI) in patients with acute chest pain. Posterior chest leads (V7-V9) and/or right-sided precordial leads (V3R-V5R) provide important information from those specific areas, but these additional ECGs are not routinely recorded because of the time-consuming procedure involved. The purpose of the present study was to evaluate a newly developed system to synthesize these 6 additional lead ECGs non-invasively using standard 12-lead ECG information. Patients and Methods: Thirty patients (25 men, 5 women; mean age: 65 ± 11 years) complaining of acute chest pain were enrolled. Standard 12-lead and V3R, V4R, V5R, V7, V8, V9 lead ECGs were successively recorded and compared with synthesized ECGs mathematically derived from standard 12-lead signals. Results: The synthesized and actual ECG waveforms were almost identical, and there were significant correlations in ECG variables, including the P, QRS, and T waves (correlation coefficients about total 1-cycle signals: 0.97 in V3R; 0.93 in V4R; 0.88 in V5R; 0.98 in V7; 0.92 in V8; and 0.88 in V9, p<0.001). Both in patients with AMI (N=16) and in patients with ST elevation at the extended leads (N=8), significant correlations were also found (correlation coefficients were over 0.88 at all leads, p<0.001). The reproducibility of the ST segment was as good as that of the other ECG variables, even in patients with significant ST elevation due to posterior and/or right ventricular AMI. Conclusion: Synthesized posterior and right-sided precordial lead ECGs appear to be highly reliable and useful in the rapid diagnosis of AMI, especially in the early detection of posterior and/or right ventricular involvement, thereby alleviating patient distress.
- 1 January 2011
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 78 (1) , 22-29
Open AccessClinical Significance of Synthesized Posterior/Right-Sided Chest Lead Electrocardiograms in Patients with Acute Chest Pain
Background: 12-lead electrocardiograms (ECGs) provide insufficient information for the accurate diagnosis of posterior and/or right ventricular acute myocardial infarction (AMI) in patients with acute chest pain. Posterior chest leads (V7-V9) and/or right-sided precordial leads (V3R-V5R) provide important information from those specific areas, but these additional ECGs are not routinely recorded because of the time-consuming procedure involved. The purpose of the present study was to evaluate a newly developed system to synthesize these 6 additional lead ECGs non-invasively using standard 12-lead ECG information. Patients and Methods: Thirty patients (25 men, 5 women; mean age: 65 ± 11 years) complaining of acute chest pain were enrolled. Standard 12-lead and V3R, V4R, V5R, V7, V8, V9 lead ECGs were successively recorded and compared with synthesized ECGs mathematically derived from standard 12-lead signals. Results: The synthesized and actual ECG waveforms were almost identical, and there were significant correlations in ECG variables, including the P, QRS, and T waves (correlation coefficients about total 1-cycle signals: 0.97 in V3R; 0.93 in V4R; 0.88 in V5R; 0.98 in V7; 0.92 in V8; and 0.88 in V9, p<0.001). Both in patients with AMI (N=16) and in patients with ST elevation at the extended leads (N=8), significant correlations were also found (correlation coefficients were over 0.88 at all leads, p<0.001). The reproducibility of the ST segment was as good as that of the other ECG variables, even in patients with significant ST elevation due to posterior and/or right ventricular AMI. Conclusion: Synthesized posterior and right-sided precordial lead ECGs appear to be highly reliable and useful in the rapid diagnosis of AMI, especially in the early detection of posterior and/or right ventricular involvement, thereby alleviating patient distress.
- Open Access
- 1 January 2010
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 74 (9) , 1906-1915
V-Shaped Trough in Autonomic Activity Is a Possible Precursor of Life-Threatening Cardiac Events
Background: No reliable precursor of sudden cardiac death is known. Methods and Results: Holter electrocardiograms of 34 patients experiencing a cardiac event (event group, 20 deaths) were compared with 191 controls (no event group). The event group included 25 patients with ventricular fibrillation or acute myocardial infarction (AMI), and 9 with cardiac arrest due to complete atrioventricular block. The logarithms were calculated of the moving average of 5 successive values for the low-frequency component (LF), the high-frequency component (HF), and the ratio LF/HF of heart rate variability: ln(LF), ln(HF) and ln(LF/HF). A V-shaped trough appeared in the curve of ln(LF/HF) [sV-trough] or ln(HF) [pV-trough] before such an event in 31 patients in the event group. The V-trough was marked by a small variation lasting 2 h, an abrupt descent lasting 30 min, and a sharp ascent for 40 min. An sV-trough was observed in 22 patients before the onset of ventricular fibrillation or AMI. A pV-trough was observed in all 9 patients before the onset of complete atrioventricular block. In the no event group, an sV-trough and a pV-trough were observed in 10 subjects (5%) and 20 subjects (10%), respectively. The positive predictive accuracy of an sV-trough for ventricular fibrillation or AMI and that of a pV-trough for complete atrioventricular block was 88% and 100%, respectively. Conclusions: A previously unidentified V-trough of autonomic activity is a potential precursor of lethal events. (Circ J 2010; 74: 1906 - 1915)
- 1 January 2010
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 74 (9) , 1906-1915
Open AccessV-Shaped Trough in Autonomic Activity Is a Possible Precursor of Life-Threatening Cardiac Events
Background: No reliable precursor of sudden cardiac death is known. Methods and Results: Holter electrocardiograms of 34 patients experiencing a cardiac event (event group, 20 deaths) were compared with 191 controls (no event group). The event group included 25 patients with ventricular fibrillation or acute myocardial infarction (AMI), and 9 with cardiac arrest due to complete atrioventricular block. The logarithms were calculated of the moving average of 5 successive values for the low-frequency component (LF), the high-frequency component (HF), and the ratio LF/HF of heart rate variability: ln(LF), ln(HF) and ln(LF/HF). A V-shaped trough appeared in the curve of ln(LF/HF) [sV-trough] or ln(HF) [pV-trough] before such an event in 31 patients in the event group. The V-trough was marked by a small variation lasting 2 h, an abrupt descent lasting 30 min, and a sharp ascent for 40 min. An sV-trough was observed in 22 patients before the onset of ventricular fibrillation or AMI. A pV-trough was observed in all 9 patients before the onset of complete atrioventricular block. In the no event group, an sV-trough and a pV-trough were observed in 10 subjects (5%) and 20 subjects (10%), respectively. The positive predictive accuracy of an sV-trough for ventricular fibrillation or AMI and that of a pV-trough for complete atrioventricular block was 88% and 100%, respectively. Conclusions: A previously unidentified V-trough of autonomic activity is a potential precursor of lethal events. (Circ J 2010; 74: 1906 - 1915)
- Open Access
- 1 January 2009
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 133 (1) , 19-21
Clinical background of drug-induced long QT syndrome
薬物使用中に心電図QT/QTc間隔が異常に延長する病態を薬物性QT延長症候群という.心臓薬のみならず非心臓薬でも起こりうることが指摘され,その一部はtorsades de pointes型心室頻拍などの致死性不整脈を惹起することが報告されて以来,臨床の現場で広く注意が喚起されるに至っている.一方で,新たに開発されてくるさまざまな薬剤に関しても,安全性重視の観点から,薬剤の薬理学的作用によってたとえ軽度であってもQT/QTc間隔を延長させることがないかを,厳密な方法でかつ客観的に証明することが国際調和会議の中で求められるようになってきた.すなわち,新規薬剤開発のための臨床試験計画において,詳細な心電図記録・計測・評価システムを含む試験プロトコールを立案することが不可欠である.しかし実際の臨床においては,QT/QTc間隔をはじめとする種々の心電図指標値は,当該薬剤の薬理作用のみならず他のさまざまな患者要因の影響を受けて大きく変動する.薬剤の持つ純粋なQT延長作用の有無を正確に評価することのできる,よい試験プロトコールを立案するためには,対象薬剤の薬理作用を詳細に把握しておくことが肝要であるのは言うまでもなく,対象患者のさまざまな臨床背景を充分に考慮に入れることが重要である.
- 1 January 2009
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 133 (1) , 19-21
Open AccessClinical background of drug-induced long QT syndrome
薬物使用中に心電図QT/QTc間隔が異常に延長する病態を薬物性QT延長症候群という.心臓薬のみならず非心臓薬でも起こりうることが指摘され,その一部はtorsades de pointes型心室頻拍などの致死性不整脈を惹起することが報告されて以来,臨床の現場で広く注意が喚起されるに至っている.一方で,新たに開発されてくるさまざまな薬剤に関しても,安全性重視の観点から,薬剤の薬理学的作用によってたとえ軽度であってもQT/QTc間隔を延長させることがないかを,厳密な方法でかつ客観的に証明することが国際調和会議の中で求められるようになってきた.すなわち,新規薬剤開発のための臨床試験計画において,詳細な心電図記録・計測・評価システムを含む試験プロトコールを立案することが不可欠である.しかし実際の臨床においては,QT/QTc間隔をはじめとする種々の心電図指標値は,当該薬剤の薬理作用のみならず他のさまざまな患者要因の影響を受けて大きく変動する.薬剤の持つ純粋なQT延長作用の有無を正確に評価することのできる,よい試験プロトコールを立案するためには,対象薬剤の薬理作用を詳細に把握しておくことが肝要であるのは言うまでもなく,対象患者のさまざまな臨床背景を充分に考慮に入れることが重要である.
- Open Access
- 1 January 2007
- Published by Wiley in Journal of Arrhythmia
- Vol. 23 (2) , 131-139
Efficacy and Safety of Intravenous Amiodarone Infusion in Japanese Patients with Hemodynamically Compromised Ventricular Tachycardia or Ventricular Fibrillation
- 1 January 2007
- Published by Wiley in Journal of Arrhythmia
- Vol. 23 (2) , 131-139
Open AccessEfficacy and Safety of Intravenous Amiodarone Infusion in Japanese Patients with Hemodynamically Compromised Ventricular Tachycardia or Ventricular Fibrillation
- Open Access
- 1 January 2006
- Published by Wiley in Journal of Arrhythmia
- Vol. 22 (3) , 155-160
Acute Effects on Signal-Averaged Electrogram Parameters and Suppressing Premature Ventricular Contractions in Single or Combined Use of Class I Antiarrhythmic Drugs
- 1 January 2006
- Published by Wiley in Journal of Arrhythmia
- Vol. 22 (3) , 155-160
Open AccessAcute Effects on Signal-Averaged Electrogram Parameters and Suppressing Premature Ventricular Contractions in Single or Combined Use of Class I Antiarrhythmic Drugs